FDA.reportPublic FDA data

LactoVive

Manufacturer
Lifsa Drugs LLC
Effective date
2025-03-18
Label type
DIETARY SUPPLEMENT
Version
1
Source
full-release
Hydrated at
2026-06-01 02:51:32

Label at a glance#

ProductLactoVive
Active ingredientLACTOBACILLUS ACIDOPHILUS, BIFIDOBACTERIUM ANIMALIS LACTIS
Label structure12 sections

Dosage and administration

Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.

Storage and handling

Store 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Avoid excessive heat, light, moisture and exceeding 85% humidity. Keep in a cool, dry place. TAMPER EVIDENT: Do not use if seal is broken or missing.

Label contents#

Full prescribing information#

HEALTH CLAIM SECTION

72336-172-30

PROBIOTIC SUPPORT

DIETARY SUPPLEMENT

DISPENSED BY PRESCRIPTION

DESCRIPTION

HEALTH CLAIM SECTION

LactoVive is an orally administered prescription probiotic dietary supplement.

STATEMENT OF IDENTITY SECTION

Supplement Facts
Serving size 1 Capsule
Amount per Serving:% Daily Value
Lactobacillus Acidophilus16 Billion*
Bifidobacterium Animalis Lactis15 Billion*

* Daily value not established

Inactive Ingredients:

Vegetable Capsules

Hydroxypropyl Methylcellulose, Silicon Dioxide, Magnesium Stearate.

Preservative Free and Gluten Free

INDICATIONS

HEALTH CLAIM SECTION

LactoVive is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed. LactoVive should be administered under the supervision of a licensed medical practitioner.

CONTRAINDICATIONS

HEALTH CLAIM SECTION

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

WARNINGS SECTION

LactoVive should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

ADVERSE REACTIONS

HEALTH CLAIM SECTION

You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Lifsa Drugs, LLC at 1-800-FDA-1088

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Usual adult dose is 1 capsule once or twice daily or as prescribed by a licensed medical practitioner.

HOW SUPPLIED

HEALTH CLAIM SECTION

Bottle of 30 capsules (72336-172-30)

STORAGE AND HANDLING

SAFE HANDLING WARNING SECTION

Store 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Avoid excessive heat, light, moisture and exceeding 85% humidity. Keep in a cool, dry place.

TAMPER EVIDENT: Do not use if seal is broken or missing.

HEALTH CLAIM SECTION

31 Billion CFU's verified at the time of production.

Manufactured For:

Lifsa Drugs, LLC

New Brunswick NJ 08901

MADE IN USA

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any diseases.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

PRINCIPAL DISPLAY PANEL - 30 Capsule Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

72336-172-30

Lactobacillus Acidophilus
Bifidobacterium Animalis Lactis
31 Billion CFU's
30 CAPSULES

LactoVive-3LactoVive-3

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2043695Lactobacillus acidophilus 16 Billion UNT / Bifidobacterium animalis 15 Billion UNT Oral CapsulePSN1
2043695Bifidobacterium animalis 15000000000 UNT / Lactobacillus acidophilus 16000000000 UNT Oral CapsuleSCD1
2043695Bifidobacterium animalis 15,000,000,000 UNT / Lactobacillus acidophilus 16,000,000,000 UNT Oral CapsuleSY1
2043695Bifidobacterium animalis lactis 15,000,000,000 UNT / Lactobacillus acidophilus 16,000,000,000 UNT Oral CapsuleSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72336-172-30LactoVive30 in 1 BOTTLECAPSULE301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72336-172LACTOVIVE (LACTOBACILLUS ACIDOPHILUS, BIFIDOBACTERIUM ANIMALIS LACTIS) CAPSULE [LIFSA DRUGS LLC]11 package rows20250323_ee98f4b2-1fd0-463a-a31b-32f3b7fd83d1.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72336-172-30EA - Each72336-172f7984690-b89d-4ea4-8079-217cc1561c2f12025-05-14

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72336-17272336-172-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
LACTOBACILLUS ACIDOPHILUS1PRR1V42V5ACTIB
BIFIDOBACTERIUM ANIMALIS LACTIS5307V7XW8IACTIB
HYPROMELLOSE, UNSPECIFIED3NXW29V3WOIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
MAGNESIUM STEARATE70097M6I30IACT

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.